Literature DB >> 16256416

A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population.

Zheng-Guo Cao1, Cheng-Zhang Li.   

Abstract

We genotyped 96 oral squamous cell carcinoma (OSCC) patients for the 1G/2G polymorphism of matrix metalloproteinase-1 (MMP-1) promoter -1607 bp using PCR-RFLP. A control population of 120 frequency-matched subjects was also genotyped for the same polymorphism. The detection frequency of 2G allele was significantly higher in OSCC subjects (76%) than in the control group (56.7%). The frequency of 2G allele had a significant difference between the OSCC and controls group (p = 0.00, Odds Ratio, OR = 2.232, 95% CI = 1.477-3.372). The genotype 2G/2G was found in 57.3% of the OSCC, and 34.2% in the controls. The proportion of 2G homozygote (2G/2G) was significantly higher in the OSCC group when compared to controls (p = 0.001, OR = 2.585, 95% CI = 1.487-4.494). OSCC patients were stratified by clinicopathological parameters including gender, smoking, clinical stage and lymph node metastasis, but the only statistically significant association with MMP-1 genotype was with smoking. The results showed that a SNP in the MMP-1 promoter -1607 bp was associated with OSCC susceptibility in a Chinese population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256416     DOI: 10.1016/j.oraloncology.2004.08.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Lili Lu; Yujiao Sun; Yiqun Li; Ping Wan
Journal:  Tumour Biol       Date:  2014-11-13

2.  Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Authors:  Marni Stott-Miller; John R Houck; Pawadee Lohavanichbutr; Eduardo Méndez; Melissa P Upton; Neal D Futran; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

3.  Expression of E-cadherin and vimentin in oral squamous cell carcinoma.

Authors:  Jingping Zhou; Detao Tao; Qing Xu; Zhenlin Gao; Daofang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population.

Authors:  Nitin Malik; Raj Kumar; Kashi N Prasad; Priyanka Kawal; Arun Srivastava; Ashok K Mahapatra
Journal:  J Neurooncol       Date:  2010-08-14       Impact factor: 4.130

5.  Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.

Authors:  Guoda Han; Zhijiang Wei; Zhiliang Lu; Haibin Cui; Xiyong Bai; Huai'e Ge; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 6.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

7.  Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.

Authors:  Xiqiang Liu; Anxun Wang; Lorenzo Lo Muzio; Antonia Kolokythas; Shihu Sheng; Corrado Rubini; Hui Ye; Fei Shi; Tianwei Yu; David L Crowe; Xiaofeng Zhou
Journal:  BMC Cancer       Date:  2010-07-09       Impact factor: 4.430

8.  Zinc dependent endopeptidases of matrix metalloproteinases-9 expressions is associated with tumor metastases of oral squamous cell carcinoma in Chinese population: a meta-analysis.

Authors:  De-Tao Tao; Zhen-Lin Gao; Jing-Ping Zhou; Lian-Ping He; Liu-Xia Shi; Yuan Fang; Wen-Jing Liu; Chao Deng
Journal:  Int J Clin Exp Med       Date:  2014-06-15

9.  MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.

Authors:  Xiqiang Liu; Jinsheng Yu; Lu Jiang; Anxun Wang; Fei Shi; Hui Ye; Xiaofeng Zhou
Journal:  Cancer Genomics Proteomics       Date:  2009 May-Jun       Impact factor: 4.069

10.  Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma.

Authors:  Hui Ye; Anxun Wang; Bao-Shiang Lee; Tianwei Yu; Shihu Sheng; Tingsheng Peng; Shen Hu; David L Crowe; Xiaofeng Zhou
Journal:  Cancer Genomics Proteomics       Date:  2008 Mar-Apr       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.